-
Nivolumab
-
BD00757104946414-94-495%
-
¥1710.01mg
-
Ethyl (2-(benzo[c][1,2,5]oxadiazol-5-ylmethoxy)-4-((2-bromo-[1,1'-biphenyl]-3-yl)methoxy)-5-chlorobenzyl)-D-serinate hydrochloride
-
BD014478632597056-04-598%
-
¥3630.01g
-
(2-((3-Cyanobenzyl)oxy)-4-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)-5-nitrobenzyl)-L-threonine
-
BD014537702487550-41-298%
-
¥5567.0100mg
-
(2-((3-Cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)-5-methylbenzyl)-D-serine hydrochloride
-
BD011661812113650-04-598%
-
¥429.01mg
-
(3S,5R,8R,9R,10R,12R,13R,14R,17S)-4,4,8,10,14-Pentamethyl-17-((R)-2,6,6-trimethyltetrahydro-2H-pyran-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol
-
BD928719666-76-398%
-
¥373.025mg
-
(2R,4R)-1-(5-Chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)-4-hydroxypyrrolidine-2-carboxylic acid
-
BD011421251818314-88-399%
-
¥2901.0100mg
-
Durvalumab
-
BD011161301428935-60-795%
-
¥1398.05mg
-
N-(2-((4-((2-Methyl-[1,1'-biphenyl]-3-yl)methoxy)-1,3,5-triazin-2-yl)amino)ethyl)acetamide
-
BD015093362767424-13-398%
-
¥960.05mg
-
(5S,5'S)-5,5'-(((((2,2'-Dichloro-[1,1'-biphenyl]-3,3'-diyl)bis(3-methoxypyrazine-5,2-diyl))bis(methylene))bis(azanediyl))bis(methylene))bis(pyrrolidin-2-one)
-
BD014678272374856-75-295%
-
¥1019.010mg
-
3,6-Diamino-9-(2-(methoxycarbonyl)phenyl)xanthylium chloride
-
BD15035462669-70-995%
-
¥1728.0250mg
-
(S)-2-(3-((S)-4-Amino-1-(5-((1S,2R)-1-amino-2-hydroxypropyl)-1,3,4-oxadiazol-2-yl)-4-oxobutyl)ureido)-3-hydroxypropanoic acid
-
BD010689951673560-66-198+%
-
¥1166.025mg
-
N-(2-(((2-Methoxy-6-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)pyridin-3-yl)methyl)amino)ethyl)acetamide
-
BD6277991675203-84-598%
-
¥1212.0100mg
-
Atezolizumab
-
BD010987731380723-44-398%
-
¥4750.025mg
-
N,N'-(2,2'-Dimethyl-[1,1'-biphenyl]-3,3'-diyl)bis(5-(((2-hydroxyethyl)amino)methyl)picolinamide)
-
BD014626202368182-63-099%
-
¥652.05mg
-
4-(2-(10H-Phenothiazin-10-yl)ethyl)morpholine
-
BD018768334734-59-298%
-
¥681.050mg
-
1-(3-Bromo-4-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)benzyl)piperidine-2-carboxylic acid
-
BD011457181675201-90-798%
-
¥783.0100mg
-
(S)-1-(2,6-Dimethoxy-4-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)benzyl)piperidine-2-carboxylic acid
-
BD3283961675201-83-898%
-
¥1043.050mg
-
Pembrolizumab
-
BD011088541374853-91-498%
-
¥1710.01mg
-
(R)-1-((7-Cyano-2-(3'-((3-(((R)-3-hydroxypyrrolidin-1-yl)methyl)-1,7-naphthyridin-8-yl)amino)-2,2'-dimethyl-[1,1'-biphenyl]-3-yl)benzo[d]oxazol-5-yl)methyl)pyrrolidine-3-carboxylic acid
-
BD014162422230911-59-698%
-
¥3904.050mg